期刊文献+

胺碘酮与利多卡因对急性心肌梗死并室性心律失常的疗效比较 被引量:3

Comparison of Curative Effect of Amiodarone and Lidocaine on Patients with Acute Myocardial Infarction and Ventricular Arrhythmias
下载PDF
导出
摘要 目的探讨急性心机梗死并室性心律失常患者利用胺碘酮和利多卡因治疗的临床疗效。方法该研究采用回顾性分析的方法随机选取了2014年3月—2015年6月于该院就诊的70例急性心肌梗死并室性心律失常患者,分为观察组与对照组两组各35例。观察组的急性心肌梗死并室性心律失常患者用胺碘酮来治疗,对照组用利多卡因来治疗,记录并比较在治疗后观察组和对照组患者的临床疗效。结果观察组的治疗有效率(94.3%)明显高于对照组的治疗有效率(82.3%),观察组的死亡率(2.9%)明显低于对照组的死亡率(11.4%),观察组的不良反应发生率(8.6%)明显低于对照组的不良反应发生率(22.9%),经比较后差异有统计学意义(P<0.05)。结论急性心肌梗死并室性心律失常患者利用胺碘酮进行治疗的临床疗效优于利用利多卡因进行治疗的临床疗效,胺碘酮治疗的安全性较高,具有临床上推广与应用的价值。 Objective To study the clinical curative effect of amiodarone and lidocaine on patients with acute myocardial infarction and ventricular arrhythmias. Methods 70 cases of patients with acute myocardial infarction and ventricular arrhythmias diagnosed in our hospital from March 2014 to June 2015 were retrospectively analyzed and divided into two groups with 35 cases in each, the observation group were treated with amiodarone, the control group were treated with lidocaine, and the clinical curative effects of the two groups after treatment were recorded and compared. Results The treatment effective rate in the observation group was obviously higher than that in the control group,(94.3% vs 82.3%), and the death rate in the observation group was obviously lower than that in the control group,(2.9% vs 11.4%), and the incidence rate of adverse reactions in the observation group was obviously lower than that in the control group,(8.6% vs 22.9%), and the differences were obvious by comparison with statistical significance, P〈0.05. Conclusion The clinical curative effect of amiodarone in treatment of patients with acute myocardial infarction and ventricular arrhythmias is better than that of lidocaine treatment with higher safety, which is worth clinical promotion and application.
作者 张发意
出处 《中外医疗》 2016年第12期153-154,178,共3页 China & Foreign Medical Treatment
关键词 胺碘酮 利多卡因 急性心肌梗死并室性心律失常 临床疗效 Amiodarone Lidocaine Acute myocardial infarction and ventricular arrhythmias Clinical curative effect
  • 相关文献

参考文献8

二级参考文献35

  • 1刘相星,杨春强,王跃明,庄建群,秦毅.室性心律失常患者血浆C反应蛋白水平观察[J].中华心律失常学杂志,2006,10(1):59-60. 被引量:15
  • 2殷实,黄亚辉,公兰兰.倍他乐克联合胺碘酮、门冬氨酸钾镁对急性心肌梗塞早期并发室颤的救治[J].心血管康复医学杂志,2007,16(2):168-169. 被引量:11
  • 3颜光美.药理学[M].北京:高等教育出版社,2006:262-266.
  • 4Harry A.Efficacy and toxiciyy of amiodarone for the treatments of supraventricular tachyarrhythmias.Prcgress in Cardiorasular Diseases,1989,(51):355.
  • 5王聆训.胺碘酮的毒副反应及防治[J].实用内科杂志,1998,(6):323-323.
  • 6高长昀,江毅,肖骏,胡有志.胺碘酮与利多卡因对急性心肌梗死并室性心律失常的疗效比较[J].华中科技大学学报(医学版),2007,36(4):542-543. 被引量:30
  • 7Hirasawa Y, Nakagomi A, Kobyashi Y ,et al.Short-term amiodarone treat-ment attenuates the production of monocyte cytokines and chemokines byC-reactive protein and improves cardiac function in patients with idio-pathic dilated cardiomyopathy and ventricular tachycardia [ J ] .Circ J,2009;73(4):63946.
  • 8Antman EM,Anbe DT, Armstrong PW,et al. ACC/AHA Guide- lines for the Management of Patients with ST - Elevation Myocar- dial Infarction - Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines(Writing Committee to Revise the 1999 Guide- lines for the Management of Patients With Acute Myocardial In- farction) [J]. Circulation, 2004,110 : 588 - 636.
  • 9Hirasawa Y,Nakagomi A,Kobyashi Y,et al.Short-term amiodarone treatment attenuates wht productont of moncyte cytokines and chemokines by C-reactive protein and improves cardiac function in patients with idiopathic dilated cardiomyopathy and ventricular thchycardia[J].Circ J,2009,73(4):639-646.
  • 10Harkness JR,Morrow DA,Braunwald E,et al.Myocardial ischemia and ventricular tachycardia on continuous electrocardiographic monitoring and risk of cardiovascular outcomes after non-ST-segment elevation acute coronary syndrome[J].Am J Cardiol,2011,108(10):1373-1381.

共引文献151

同被引文献15

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部